New drug calms dementia agitation in phase 3 trial
NCT ID NCT05271552
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 20 times
Summary
This study tested a medicine called BXCL501 for calming sudden episodes of agitation in people with dementia. 151 participants took the medicine or a placebo as needed over 12 weeks. The goal was to see if the medicine safely reduces agitation symptoms like tension and hostility.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BioXcel Clinical Research Site
Phoenix, Arizona, 85016, United States
-
BioXcel Clinical Research Site
Long Beach, California, 90806, United States
-
BioXcel Clinical Research Site
Daytona Beach, Florida, 32117, United States
-
BioXcel Clinical Research Site
Lady Lake, Florida, 32159, United States
-
BioXcel Clinical Research Site
Maitland, Florida, 32751, United States
-
BioXcel Clinical Research Site
Miami Lakes, Florida, 33016, United States
-
BioXcel Clinical Research Site
North Miami, Florida, 33161, United States
-
BioXcel Clinical Research Site
Marrero, Louisiana, 70072, United States
-
BioXcel Clinical Research Site
Springfield, Massachusetts, 01103, United States
-
BioXcel Clinical Research Site
Berlin, New Jersey, 08009, United States
-
BioXcel Clinical Research Site
Toms River, New Jersey, 08755, United States
Conditions
Explore the condition pages connected to this study.